Publicaciones en las que colabora con Julio Bobes García (14)

2024

  1. The mediating role of reflective functioning in the association between childhood trauma and suicide attempt

    Journal of Psychiatric Research, Vol. 171, pp. 30-37

2019

  1. CIBERSAM: Ten years of collaborative translational research in mental disorders

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8

2018

  1. Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

    The Lancet Psychiatry, Vol. 5, Núm. 10, pp. 797-807

2014

  1. Replication of previous genome-wide association studies of psychiatric diseases in a large schizophrenia case-control sample from Spain

    Schizophrenia Research, Vol. 159, Núm. 1, pp. 107-113

2012

  1. Pregabalin for the discontinuation of long-term benzodiazepines use: An assessment of its effectiveness in daily clinical practice

    European Psychiatry, Vol. 27, Núm. 4, pp. 301-307

2011

  1. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use

    European Addiction Research, Vol. 17, Núm. 5, pp. 262-270

2010

  1. Rendimiento psicométrico de la sexta versión del Addiction Severity Index en español (ASI-6)

    Psicothema, Vol. 22, Núm. 3, pp. 513-519

2005

  1. Safety and effectiveness of olanzapine in monotherapy: A multivariate analysis of a naturalistic study

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 29, Núm. 6, pp. 944-951

  2. Safety, effectiveness, and patterns of use of olanzapine in acute schizophrenia: A multivariate analysis of a large naturalistic study in the hospital setting

    Medicina Clinica, Vol. 124, Núm. 13, pp. 481-486

2003

  1. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 27, Núm. 3, pp. 473-481

  2. Safety of olanzapine versus conventional antipsychotics in the treatment of patients with acute schizophrenia. A naturalistic study

    European Neuropsychopharmacology, Vol. 13, Núm. 1, pp. 39-48

2002

  1. Treatment of severely psychotic inpatients with schizophrenia: Olanzapine versus other antipsychotic drugs

    International Clinical Psychopharmacology, Vol. 17, Núm. 6, pp. 287-295

2001

  1. Abuso y dependencia de tóXIcos en pacientes psicóticos: tratados con risperidona. Disminución del consumo de cocaína y cannabis.

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 3, Núm. 4, pp. 289-290

  2. Tratamiento con risperidona en patología dual: disminución del consumo de alcohol

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 3, Núm. 4, pp. 290-290